文章来源: https://www.ctvnews.ca/health/coronavirus/canada-expected-to-finish-review-of-first-covid-19-shot-for-youngest-kids-in-weeks-1.5951775 https://www.canada.ca/en/public-health/services/vaccination-children/covid-19.html?utm_campaign=hc-sc-...
CHILDREN have now received their first doses of Moderna’s COVID-19 vaccine, as the company studies the safety and effectiveness of the vaccine for kids ages 6 months to less than 12 years old. In the study, researchers will give two injections 28 days apart of either the Moderna vaccine ...
WASHINGTON, Oct. 25 (Xinhua) -- American biotechnology company Moderna said Monday a study in children ages 6 to 11 found two doses of the company's COVID-19 vaccine given 28 days apart produced a strong antibody response. The Phase 2/3 study, called the KidCOVE study, gave participants...
TIRRELL: And Stéphane, where do things stand with a vaccine for kids from Moderna, you know, with Pfizer’s getting delayed to some extent by a few months, there is a gap in coverage in the US for kids under five. Moderna, of course, is still waiting for cleara...
Moderna Spikevax is the second COVID-19 vaccine to receive full FDA approval! Find out what this means, and how it differs from the EUA!
They un- enrolled Sam from the study so he could get the Pfizer vaccine. Rodriguez said the whole experience of getting her children vaccinated has been a huge relief. "The last two years have been nothing that we would have ever imagined. Having vaccines for these youngest kids feels like...
For the Pfizer-BioNTech vaccine, the FDA amended the EUA to include use of the vaccine in individuals 6 months through 4 years of age. The vaccine had previously been authorized for use in individuals 5 years of age and older. The FDA said its evaluation and analysis of the safety, effect...
Moderna said it has started the process of obtaining full approval of its COVID-19 vaccine. It will submit data “on a rolling basis over the coming weeks,” which the FDA will scrutinize.
Drug company Moderna is unveiling its research results, saying its coronavirus vaccine is nearly 95 percent effective. The promising news comes as the U.S. surpasses 11 million coronavirus cases and the CDC predicts 35,000 more deaths by December. NBC’s Miguel Almaguer reports for TODAY....
Moderna says its COVID-19 vaccine strongly protects kids as young as 12. The company released the preliminary findings Tuesday based on testing on more than 3,700 12- to 17-year-olds in the United States.